生物标志物 生物标志物
Maryam Ghahremani1, Rebeca Leon1, Eric E Smith1,2
1Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
轻度行为障碍 (MBI) 与较高的血p-tau217水平有关,这表明MBI可能表明阿尔茨海默病 (AD) 蛋白质病变. 这一发现支持MBI在早期AD检测和风险分层方面的作用.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物 生物标志物
- 老年学是指老年学的学科.
背景情况:
- 2024年NIA-AA标准使用粉样β和生物标志物定义了阿尔茨海默病 (AD).
- 轻度行为障碍 (MBI),以持续的神经精神症状为特征,可能会先于认知能力下降,并表明痴呆风险.
- 目前,MBI与血p-tau217,AD病理学的新型血液生物标志物之间的关联尚未被探索.
研究的目的:
- 调查老年人MBI和血p-tau217水平之间的关联.
- 探索MBI作为潜在的AD相关病理的早期指标,使用血p-tau217.7.
主要方法:
- 在两次访问中使用神经精神科目录评估神经精神病症状 (NPS) 来确定MBI状态.
- 利用线性和逻辑回归来建模MBI状态与血p-tau217水平之间的关联.
- 根据阿尔茨海默氏病神经成像计划参与者的年龄,性别,教育和认知诊断进行调整的模型.
主要成果:
- 与没有MBI的参与者相比,MBI的参与者表现出明显更高的血p-tau217水平.
- 患有MBI的个体显示出患有血p-tau217水平升高 (阳性) 的几率增加.
- 该研究包括101名参与者 (平均年龄为72.0±6.5岁;44.6%是女性;50.5%有轻度认知障碍).
结论:
- MBI与血p-tau217的升高有关,支持其在代表AD蛋白质病变中的作用.
- MBI评估可能有助于在临床试验中早期发现AD和风险分层.
- 研究结果强调了MBI在识别具有AD生物标志物阳性个体方面的潜在实用性.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516